{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T07:17:48Z","timestamp":1791357468535,"version":"4.3.1"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology Biochemistry and Behavior"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1016\/j.pbb.2015.06.012","type":"journal-article","created":{"date-parts":[[2015,7,4]],"date-time":"2015-07-04T20:15:24Z","timestamp":1436040924000},"page":"7-12","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"special_numbering":"C","title":["Effects of amycenone on serum levels of tumor necrosis factor-\u03b1, interleukin-10, and depression-like behavior in mice after lipopolysaccharide administration"],"prefix":"10.1016","volume":"136","author":[{"given":"Wei","family":"Yao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji-chun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cun","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susumu","family":"Hirota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazutoyo","family":"Inanaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pbb.2015.06.012_bb0005","doi-asserted-by":"crossref","first-page":"464238","DOI":"10.1155\/2012\/464238","article-title":"Evaluation of selected culinary-medicinal mushrooms for antioxidant and ACE inhibitory activities","volume":"2012","author":"Abdullah","year":"2012","journal-title":"Evid. Based Complement. Alternat. Med."},{"issue":"12","key":"10.1016\/j.pbb.2015.06.012_bb0010","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/nrn3820","article-title":"Polyunsaturated fatty acids and their metabolites in brain function and disease","volume":"15","author":"Bazinet","year":"2014","journal-title":"Nat. Rev. Neurosci."},{"issue":"9","key":"10.1016\/j.pbb.2015.06.012_bb0015","doi-asserted-by":"crossref","first-page":"707","DOI":"10.18632\/aging.100690","article-title":"Reversal of cognitive decline: a novel therapeutic program","volume":"6","author":"Bredesen","year":"2014","journal-title":"Aging (Alnaby NY)"},{"issue":"1","key":"10.1016\/j.pbb.2015.06.012_bb0020","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s00213-011-2619-3","article-title":"Protective effects of the antioxidant sulforaphane on behavioral changes and neurotoxicity in mice after the administration of methamphetamine","volume":"222","author":"Chen","year":"2012","journal-title":"Psychopharmacology (Berlin)"},{"issue":"9","key":"10.1016\/j.pbb.2015.06.012_bb0025","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1038\/nrd1825","article-title":"The ascent of mouse: advances in modeling human depression and anxiety","volume":"4","author":"Cryan","year":"2005","journal-title":"Nat. Rev. Drug Discov."},{"issue":"1","key":"10.1016\/j.pbb.2015.06.012_bb0030","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/nrn2297","article-title":"From inflammation to sickness and depression: when the immune system subjugates the brain","volume":"9","author":"Dantzer","year":"2008","journal-title":"Nat. Rev. Neurosci."},{"issue":"5","key":"10.1016\/j.pbb.2015.06.012_bb0035","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.biopsych.2009.09.033","article-title":"A meta-analysis of cytokines in major depression","volume":"67","author":"Dowlati","year":"2010","journal-title":"Biol. Psychiatry"},{"issue":"Suppl. 1","key":"10.1016\/j.pbb.2015.06.012_bb0040","doi-asserted-by":"crossref","first-page":"S55","DOI":"10.1017\/S000711451400333X","article-title":"Maternal depression, stress and feeding styles: towards a framework for theory and research in child obesity","volume":"113","author":"El-Behadli","year":"2015","journal-title":"Br. J. Nutr."},{"issue":"2","key":"10.1016\/j.pbb.2015.06.012_bb0045","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.brainresrev.2009.05.005","article-title":"Emerging role of glutamate in the pathophysiology of major depressive disorder","volume":"61","author":"Hashimoto","year":"2009","journal-title":"Brain Res. Rev."},{"issue":"9","key":"10.1016\/j.pbb.2015.06.012_bb0050","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1517\/14728222.2014.934225","article-title":"Targeting of NMDA receptors in new treatments for schizophrenia","volume":"18","author":"Hashimoto","year":"2014","journal-title":"Expert Opin. Ther. Targets"},{"issue":"4","key":"10.1016\/j.pbb.2015.06.012_bb0055","doi-asserted-by":"crossref","first-page":"7796","DOI":"10.3390\/ijms16047796","article-title":"Inflammaory biomarkers as differential predictors of antidepressant response","volume":"16","author":"Hashimoto","year":"2015","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.pbb.2015.06.012_bb0065","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.pmu.2012.05.003","article-title":"Amycenone, a nootropic found in Hericium erinaceum","volume":"1","author":"Inanaga","year":"2012","journal-title":"Pers. Med. Universe"},{"key":"10.1016\/j.pbb.2015.06.012_bb0075","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.pmu.2014.02.004","article-title":"Marked improvement of neurocognitive impairment after treatment with compounds from Hericium einaceum: a case study of recurrent depressive disorder","volume":"3","author":"Inanaga","year":"2014","journal-title":"Pers. Med. Universe"},{"issue":"1","key":"10.1016\/j.pbb.2015.06.012_bb0070","first-page":"203","article-title":"Case report: recovery from schizophrenia using Amyloban\u24c73399, compounds extracted from Hericium einaceum","volume":"17","author":"Inanaga","year":"2015","journal-title":"Int. J. Emerg. Ment. Health"},{"key":"10.1016\/j.pbb.2015.06.012_bb0060","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.pmu.2014.04.002","article-title":"Improvement of refractory schizophrenia on using Amyloban\u24c73399 extracted from Hericium einaceum","volume":"3","author":"Inanaga","year":"2014","journal-title":"Pers. Med. Universe"},{"issue":"18","key":"10.1016\/j.pbb.2015.06.012_bb0080","doi-asserted-by":"crossref","first-page":"7661","DOI":"10.1007\/s00253-014-5955-5","article-title":"Medicinal properties of Hericium erinaceus and its potential to formulate novel mushroom-based pharmaceuticals","volume":"98","author":"Jiang","year":"2014","journal-title":"Appl. Microbiol. Biotechnol."},{"issue":"1","key":"10.1016\/j.pbb.2015.06.012_bb0085","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1515\/jcim-2013-0001","article-title":"Hericium erinaceus: an edible mushroom with medicinal values","volume":"10","author":"Khan","year":"2013","journal-title":"J. Complement Integr. Med."},{"issue":"1","key":"10.1016\/j.pbb.2015.06.012_bb0090","doi-asserted-by":"crossref","first-page":"181","DOI":"10.3945\/ajcn.113.069880","article-title":"A systematic review and meta-analysis of dietary patterns and depression in community-dwelling adults","volume":"99","author":"Lai","year":"2014","journal-title":"Am. J. Clin. Nutr."},{"issue":"2","key":"10.1016\/j.pbb.2015.06.012_bb0095","doi-asserted-by":"crossref","first-page":"483","DOI":"10.3892\/etm.2014.2139","article-title":"Anti-fatigue activities of polysaccharides extracted from Hericium erinaceum","volume":"9","author":"Liu","year":"2015","journal-title":"Exp. Ther. Med."},{"issue":"6","key":"10.1016\/j.pbb.2015.06.012_bb0110","doi-asserted-by":"crossref","first-page":"e20955","DOI":"10.1371\/journal.pone.0020955","article-title":"Social isolation-induced aggression potentiates anxiety and depressive-like behaviors in male mice subjected to unpredictable chronic mild stress","volume":"6","author":"Ma","year":"2011","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.pbb.2015.06.012_bb0105","doi-asserted-by":"crossref","first-page":"e56053","DOI":"10.1371\/journal.pone.0056053","article-title":"Long-lasting antidepressant action of ketamine, but not glycogen synthase kinase-3 inhibitor SB216763, in the chronic mild stress model of mice","volume":"8","author":"Ma","year":"2013","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.pbb.2015.06.012_bb0100","doi-asserted-by":"crossref","first-page":"31","DOI":"10.9758\/cpn.2014.12.1.31","article-title":"Effects of brilliant blue G on serum tumor necrosis factor-\u03b1 levels and depression-like behavior in mice after lipopolysaccharide administration","volume":"12","author":"Ma","year":"2014","journal-title":"Clin. Psychopharmacol. Neurosci."},{"issue":"3","key":"10.1016\/j.pbb.2015.06.012_bb0115","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1017\/neu.2013.52","article-title":"\u03c9-3 and major depression: a review","volume":"26","author":"Mello","year":"2014","journal-title":"Acta Neuropsychiatr."},{"issue":"9","key":"10.1016\/j.pbb.2015.06.012_bb0120","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.biopsych.2008.11.029","article-title":"Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression","volume":"65","author":"Miller","year":"2009","journal-title":"Biol. Psychiatry"},{"issue":"9","key":"10.1016\/j.pbb.2015.06.012_bb0130","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1248\/bpb.31.1727","article-title":"Nerve growth factor-inducing activity of Hericium erinaceum in 1321N1 human astrocytoma cells","volume":"31","author":"Mori","year":"2008","journal-title":"Biol. Pharm. Bull."},{"issue":"3","key":"10.1016\/j.pbb.2015.06.012_bb0125","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1002\/ptr.2634","article-title":"Improving effects of the mushroom Yamabushitake (Hericium erinaceus) on mild cognitive impairment; a double-blind placebo-controlled clinical trial","volume":"23","author":"Mori","year":"2009","journal-title":"Phytother. Res."},{"key":"10.1016\/j.pbb.2015.06.012_bb0135","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1002\/mnfr.200900157","article-title":"Dietary intake and depressive symptoms: a systemic review of observational studies","volume":"54","author":"Mukakami","year":"2010","journal-title":"Mol. Nutr. Food Res."},{"issue":"5","key":"10.1016\/j.pbb.2015.06.012_bb0140","doi-asserted-by":"crossref","first-page":"349","DOI":"10.3109\/08923973.2014.947036","article-title":"Benzyl alcohol derivatives from the mushroom Hericium erinaceum attenuate LPS-stimulated inflammatory response through the regulation of NF-\u03baB and AP-1 activity","volume":"36","author":"Noh","year":"2014","journal-title":"Immunopharmacol. Immunotoxicol."},{"issue":"5","key":"10.1016\/j.pbb.2015.06.012_bb0145","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/sj.mp.4002148","article-title":"Lipopolysaccharide-induced depressive-like behavior is mediated by indoleamine 2,3-dioxygenase activation in mice","volume":"14","author":"O'Connor","year":"2009","journal-title":"Mol. Psychiatry"},{"issue":"4","key":"10.1016\/j.pbb.2015.06.012_bb0150","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/j.pbb.2012.12.003","article-title":"Effects of antidepressants on alternations in serum cytokines and depressive-like behavior in mice after lipopolysaccharide administration","volume":"103","author":"Ohgi","year":"2013","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.pbb.2015.06.012_bb0155","first-page":"1","article-title":"The impact of whole-of-diet interventions on depression and anxiety: a systematic review of randomised controlled trials","volume":"3","author":"Opie","year":"2014","journal-title":"Public Health Nutr."},{"issue":"12","key":"10.1016\/j.pbb.2015.06.012_bb0160","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1001\/archgenpsychiatry.2010.161","article-title":"Inflammation, sanitation, and consternation: loss of contact with coevolved, tolerogenic microorganisms and the pathophysiology and treatment of major depression","volume":"67","author":"Raison","year":"2010","journal-title":"Arch. Gen. Psychiatry"},{"issue":"7","key":"10.1016\/j.pbb.2015.06.012_bb0165","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/mp.2010.52","article-title":"Altered expression of genes involved in inflammation and apoptosis in frontal cortex in major depression","volume":"16","author":"Shelton","year":"2011","journal-title":"Mol. Psychiatry"},{"issue":"2","key":"10.1016\/j.pbb.2015.06.012_bb0170","doi-asserted-by":"crossref","first-page":"94","DOI":"10.9758\/cpn.2012.10.2.94","article-title":"Effects of the antioxidant sulforaphane on hyperlocomotion and prepulse inhibition deficits in mice after phencyclidine administration","volume":"10","author":"Shirai","year":"2012","journal-title":"Clin. Psychopharmacol. Neurosci."},{"key":"10.1016\/j.pbb.2015.06.012_bb0175","doi-asserted-by":"crossref","DOI":"10.1001\/jamapsychiatry.2014.2502","article-title":"Mortality in mental disorders and global disease burden implications: a systematic review and meta-analysis","author":"Walker","year":"2015","journal-title":"JAMA Psychiatry"},{"issue":"9","key":"10.1016\/j.pbb.2015.06.012_bb0180","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S1607-551X(09)70339-0","article-title":"Antitumor and immunoenhancing activities of polysaccharide from culture broth of Hericium spp","volume":"17","author":"Wang","year":"2001","journal-title":"Kaohsiung J. Med. Sci."},{"issue":"6","key":"10.1016\/j.pbb.2015.06.012_bb0185","doi-asserted-by":"crossref","first-page":"345","DOI":"10.4103\/2319-4170.138318","article-title":"Medicinal mushroom science: current perspectives, advances, evidences, and challenges","volume":"37","author":"Wasser","year":"2014","journal-title":"Biomede J."},{"issue":"9904","key":"10.1016\/j.pbb.2015.06.012_bb0190","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1016\/S0140-6736(13)61611-6","article-title":"Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010","volume":"382","author":"Whiteford","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.pbb.2015.06.012_bb0195","first-page":"47","article-title":"Effects of cultivation techniques and processing on antimicrobial and antioxidant activities of Hericium erinaceus (Bull.:Fr.) Pers. extracts","volume":"47","author":"Wong","year":"2009","journal-title":"Food Technol. Biotechnol."},{"key":"10.1016\/j.pbb.2015.06.012_bb0200","unstructured":"World Health Organization (WHO) Depression. Fact sheet No. 369\/October 2012. Available at http:\/\/www.who.int\/mediacentre\/factsheets\/fs369\/en\/index.html."},{"issue":"6","key":"10.1016\/j.pbb.2015.06.012_bb0205","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1271\/bbb.67.1292","article-title":"Hypolipidemic effect of an Exobiopolymer produced from a submerged mycelial culture of Hericium erinaceus","volume":"67","author":"Yang","year":"2003","journal-title":"Biosci. Biotechnol. Biochem."},{"issue":"4","key":"10.1016\/j.pbb.2015.06.012_bb0210","doi-asserted-by":"crossref","first-page":"pyu077","DOI":"10.1093\/ijnp\/pyu077","article-title":"Antidepressant effects of TrkB ligands on depression-like behavior and dendritic changes in mice after inflammation","volume":"18","author":"Zhang","year":"2015","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.pbb.2015.06.012_bb0215","article-title":"Anti-dementia substance from Hericium erinaceum and method of extraction","author":"Zhuang","year":"2009","journal-title":"US Patent US"}],"container-title":["Pharmacology Biochemistry and Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091305715300228?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091305715300228?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,27]],"date-time":"2019-08-27T20:32:13Z","timestamp":1566937933000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091305715300228"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":43,"alternative-id":["S0091305715300228"],"URL":"https:\/\/doi.org\/10.1016\/j.pbb.2015.06.012","relation":{},"ISSN":["0091-3057"],"issn-type":[{"value":"0091-3057","type":"print"}],"subject":[],"published":{"date-parts":[[2015,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of amycenone on serum levels of tumor necrosis factor-\u03b1, interleukin-10, and depression-like behavior in mice after lipopolysaccharide administration","name":"articletitle","label":"Article Title"},{"value":"Pharmacology Biochemistry and Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pbb.2015.06.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}